Basis of Presentation and Summary of Significant Accounting Policies - Segment Profit or Loss (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance | ||||
| Total revenues and income | $ 78,746 | $ 115,461 | $ 194,161 | $ 208,421 |
| Other segment items: | ||||
| Amortization of intangibles | (10,205) | (8,097) | (26,399) | (24,612) |
| Interest expense | (2,898) | (910) | (6,393) | (2,930) |
| Net (loss) income | (15,758) | 55,387 | 10,693 | 25,684 |
| Other expense items, net | 46,200 | 34,500 | 88,500 | 111,600 |
| Development and Licensing of Biopharmaceutical Assets | ||||
| Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance | ||||
| Total revenues and income | 78,746 | 115,461 | 194,161 | 208,421 |
| Share-based compensation | (29,026) | (14,746) | (53,275) | (32,579) |
| Other segment items: | ||||
| Amortization of intangibles | (10,205) | (8,097) | (26,399) | (24,612) |
| Depreciation of property and equipment | (118) | (172) | (355) | (949) |
| Interest income | 5,492 | 3,874 | 19,445 | 7,266 |
| Interest expense | (2,898) | (910) | (6,393) | (2,930) |
| Other | (70,476) | 21,863 | (120,506) | (74,948) |
| Net (loss) income | $ (28,485) | $ 117,273 | $ 6,678 | $ 79,669 |
| X | ||||||||||
- Definition Other Expense Items, Net No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|